BIOCORP and Merck KGaA, Darmstadt, Germany, Sign a New Partnership for Smart Drug DeliveryBusiness Wire • 10/10/22
Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)Business Wire • 10/06/22
These Were The Five Best And Worst Performing Mega-Cap Stocks In September 202224/7 Wall Street • 10/05/22
MDA Breakout Stocks Week 40 - October 2022: Short-Term Picks To Give You An EdgeSeeking Alpha • 10/03/22
U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent LawsuitBusiness Wire • 09/29/22
Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27Business Wire • 09/29/22
Merck's KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)Business Wire • 09/27/22
MDA Breakout Stocks Week 39 - September 2022: Short-Term Picks To Give You An EdgeSeeking Alpha • 09/26/22
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key DrugsInvestors Business Daily • 09/22/22
LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevacizumab for Homologous Recombination Deficient (HRD)-Positive Advanced Ovarian CancerBusiness Wire • 09/22/22